Silverleafe Capital Partners »

Arcutis Biotherapeutics shares owned by Silverleafe Capital Partners

Quarter-by-quarter ownership of Arcutis Biotherapeutics (ARQT) shares owned by Silverleafe Capital Partners from 13F filings

Historical chart of Silverleafe Capital Partners investment in Arcutis Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Arcutis Biotherapeutics held by Silverleafe Capital Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arcutis Biotherapeutics by Silverleafe Capital Partners

Quarter filed Position value Share count Share price at filing
2025-09-30 $313k 17k 18.85
2025-06-30 $203k 15k 14.02
2025-03-31 $410k 26k 15.64

More positions owned by Silverleafe Capital Partners

Invesco Qqq Trust Series I Etf (QQQ)
Ishares Core S&p 500 Etf Etf (IVV)
Westrock Coffee Stock (WEST)
Berkshire Hathaway Inc Del Cl A Stock (BRK.A)
Fedex Corp Stock (FDX)
Apple Stock (AAPL)
Ishares Core U.s. Aggregate Bond Etf Etf (AGG)
Ishares Core Msci Eafe Etf Etf (IEFA)
First Trust Nasdaq Cybersecurity Etf Etf (CIBR)
Autozone Stock (AZO)
Ishares Expanded Tech-software Sector Etf Etf (IGV)
Range Nuclear Renaissance Index Etf Etf (NUKZ)
Global X Artificial Intelligence & Technology Etf Etf (AIQ)
Vanguard Mid-cap Etf Etf (VO)
Ishares Gold Trust Etf (IAU)

View all positions for Silverleafe Capital Partners

Top funds holding Arcutis Biotherapeutics

Jennison Associates
Rubric Capital Management
Suvretta Capital Management
Frazier Life Sciences Management
BlackRock
Vanguard Group
Polar Capital Holdings
State Street Corporation
Gilder, Gagnon, Howe & Co
Morgan Stanley
UBS Group
Geode Capital Management
Henderson Group
Franklin Resources
Pivotal bioVenture Partners Investment Advisor

View all funds holding Arcutis Biotherapeutics